Circassia strikes deal with AstraZeneca for respiratory drugs

LONDON (Reuters) - Britain's Circassia has secured the U.S. rights from AstraZeneca for two drugs to treat chronic obstructive pulmonary disease (COPD), a progressive lung condition affecting millions of people, for up to $230 million.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news